Home Trending Stocks Here is why Xeris Pharmaceuticals Inc (XERS) stock turnaround on Thursday

Here is why Xeris Pharmaceuticals Inc (XERS) stock turnaround on Thursday

Xeris Pharmaceuticals Inc. (XERS) shares gained 5.17% to trade at $4.07 in after-market on Thursday, April 29, 2021. Earlier, XERS’s stock lost 3.97% to close Thursday’s session at $3.87. XERS shares have risen by 46.04% over the last 12 months, and they have moved down 0.26% in the past week. Over the past three months, the stock has lost 25.72%, while over the past six months, it has shed 24.41%.

Let’s see is there any reason behind its flip on Thursday?


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Speculations about its upcoming Q1 earnings

The market expects Xeris Pharmaceuticals (XERS) to deliver an increase in earnings on higher revenues when it reports results for the quarter ended March 2021.

Read More

But according to Zacks estimates. The company can post a quarterly loss of $0.31 per share in its upcoming report. Also, Revenues are expected to be $7.57 million, according to Zacks.

Ogluo approval by U.K. MHRA

On April 29, 2021, Xeris Pharmaceuticals, Inc. said that its Ogluo® (glucagon) injection has been approved by the United Kingdom’s Medicines and Healthcare Regulatory Agency (MHRA).

Ogluo® (glucagon) is used for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

Glucagon injection, Gvoke is the first prescription, ready-to-use, pre-mixed, pre-measured glucagon injection was approved by the FDA in September 2019 for use in the United States.

Inducement Grants

On March 31, 2021, the Compensation Committee of Xeris granted restricted stock units for an aggregate of 15,250 shares of its common stock to 10 new employees under Xeris Inducement Equity Plan.

Recent financial result announcement

On March 8, 2021, Xeris Pharmaceuticals reported its financial results for the fourth quarter and full-year 2020.

Q4 2020 financial highlights

  • Xeris Pharmaceuticals net sales were $7.1 million for Q4 2020 compared to $1.6 million in Q4 2019
  • The cost of goods was $3.4 million in Q4 2020, compared to $1.6 million in Q4 2019.
  • R&D expenses for the fourth quarter of 2020 were 5.1 million compared to $12.4 million in Q4 2019.
  • SG&A expenses for the fourth quarter were $18.0 million compared to $20.6 million in Q4 2019.
  • Xeris suffered a net loss of $21.9 million or $0.41 per share in Q4 2020, compared to a net loss of $33.1 million, or $1.23 per share, for the same period in 2019. 

FY 2020 financial highlights

  • Xeris Pharmaceuticals net sales were $$20.2million for FY2020 compared to $1.6 million in FY 2019.
  • The cost of goods was $9.3 million in Q4 2020, compared to $1.6 million in Q4 2019.
  • R&D expenses for FY 2020 were $20.9 million compared to $60.4 million in FY 2019.
  • SG&A expenses for 2020 were $73.7 million compared to $63.1 million in 2019.
  • Xeris suffered a net loss of $91.1 million, or $2.14 per share, compared to a net loss of $125.6 million, or $4.81 per share in FY 2019.
  • Xeris reported total cash, cash equivalents, and investments of $133.8 million, as of December 31, 2020.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

The approval of Ogluo in the UK is an important development forXeris Pharmaceuticals which was the reason behind its turnaround on Thursday. XERS stock can further go up in the coming days.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Has Been Raising The Soleno (SLNO) Stock Up Before Market Open?

In recent premarket trading, Soleno Therapeutics Inc. (SLNO) has soared 3.77% at $1.10 per share. The Soleno stock closed at $1.06 yesterday, down -6.19%. Get...

Stealth BioTherapeutics Corp (MITO) Stock Going Down in PreMarket, Here’s What You Should Know

Stealth BioTherapeutics Corp (MITO) stock prices were up by a colossal 35% as of the market closing on May 6th, 2021, bringing the price...

Why Ocugen, Inc. (OCGN) stock is popping high today?

Shares of Ocugen, Inc. (OCGN) stock were popping high today on May 7, 2021, ahead of today’s earnings report.OCGN stock price saw a surge...

What Is Driving The Powerbridge (PBTS) Stock Higher In Premarket session?

At the last check, Powerbridge Technologies Co. Ltd. (NASDAQ: PBTS) shares were rising 10.71% to trade at $1.55 in premarket trades. The Powerbridge stock...

Beyond Meat, Inc. (BYND) Stock Trending Down After Management’s Uncertainty Over Fiscal Year Guidelines

Beyond Meat, Inc. (BYND) stock prices were down by 2.08% as of the market closing on May 6th, 2021, bringing the price per share...

Regional Health Properties, Inc. (RHE) Stock Skyrockets Following Trading of Exponential Volume of Shares

Regional Health Properties, Inc. (RHE) stock prices soared by 31.4% during early market hours on May 7th 2021, bringing the price per share up...

Orphazyme A/S (ORPH) Stock Plummeting After Failure of ORAIALS-01 Trial Announced

Orphazyme A/S (ORPH) stock prices plummeted by 27.77%  after the market opened on May 7th, 2021, bringing the price per share tumbling down to...

Avalon Holdings Corporation (NYSE:AWX) stock surged in the current trading session; here’s why

At last check, in the current trading session, AWX stock surged by 22.58% to $5.08. AWX stock previously closed the session at $4.14. The...

Related News

What Has Been Raising The Soleno (SLNO) Stock Up Before Market Open?

In recent premarket trading, Soleno Therapeutics Inc. (SLNO) has soared 3.77% at $1.10 per share. The Soleno stock closed at $1.06 yesterday, down -6.19%. Get...

Stealth BioTherapeutics Corp (MITO) Stock Going Down in PreMarket, Here’s What You Should Know

Stealth BioTherapeutics Corp (MITO) stock prices were up by a colossal 35% as of the market closing on May 6th, 2021, bringing the price...

Why Ocugen, Inc. (OCGN) stock is popping high today?

Shares of Ocugen, Inc. (OCGN) stock were popping high today on May 7, 2021, ahead of today’s earnings report.OCGN stock price saw a surge...

What Is Driving The Powerbridge (PBTS) Stock Higher In Premarket session?

At the last check, Powerbridge Technologies Co. Ltd. (NASDAQ: PBTS) shares were rising 10.71% to trade at $1.55 in premarket trades. The Powerbridge stock...

Beyond Meat, Inc. (BYND) Stock Trending Down After Management’s Uncertainty Over Fiscal Year Guidelines

Beyond Meat, Inc. (BYND) stock prices were down by 2.08% as of the market closing on May 6th, 2021, bringing the price per share...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.